Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CHILDRENS ADVIL

02 1CHILDRENS ADVIL-FLAVORED

03 8CLOBAZAM

04 1FELBAMATE

05 1FLO-PRED

06 1LIKMEZ

07 1LOPERAMIDE HYDROCHLORIDE

08 1NITROFURANTOIN

09 1SODIUM POLYSTYRENE SULFONATE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

NITROFURANTOIN

Drug : NITROFURANTOIN

Dosage Form : SUSPENSION; ORAL

Application Number : 201355

Country : US

Patented : No

Strides Pharma Science

02

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

CLOBAZAM

Drug : CLOBAZAM

Dosage Form : SUSPENSION; ORAL

Application Number : 210039

Country : US

Patented : No

blank

03

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

CLOBAZAM

Drug : CLOBAZAM

Dosage Form : SUSPENSION; ORAL

Application Number : 208819

Country : US

Patented : No

blank

04

arrow
APGA Annual Conference
Not Confirmed

05

arrow
APGA Annual Conference
Not Confirmed

06

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

SODIUM POLYSTYRENE SULFONATE

Drug : SODIUM POLYSTYRENE SULFONATE

Dosage Form : SUSPENSION; ORAL, RECTAL

Application Number : 89049

Country : US

Patented : No

blank

07

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

CLOBAZAM

Drug : CLOBAZAM

Dosage Form : SUSPENSION; ORAL

Application Number : 210546

Country : US

Patented : No

blank

08

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

LOPERAMIDE HYDROCHLORIDE

Drug : LOPERAMIDE HYDROCHLORIDE

Dosage Form : SUSPENSION; ORAL

Application Number : 91292

Country : US

Patented : No

blank

09

arrow
APGA Annual Conference
Not Confirmed
arrow
APGA Annual Conference
Not Confirmed

FELBAMATE

Drug : FELBAMATE

Dosage Form : SUSPENSION; ORAL

Application Number : 206314

Country : US

Patented : No

blank

10

arrow
APGA Annual Conference
Not Confirmed